Markets:

Overview

News

Currencies

International

Treasuries

Pieris Pharmaceuticals, Inc. - Common Stock (NQ:PIRS)

13.60 UNCHANGED

Last Price Updated: 4:00 PM EST, Dec 13, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Pieris Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS

November 20, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Palvella Therapeutics Announces First Patient Dosed in SELVA Phase 3 Clinical Trial of QTORIN™ 3.9% Rapamycin Anhydrous Gel (QTORIN™ rapamycin) for the Treatment of Microcystic Lymphatic Malformations

November 07, 2024

From Palvella Therapeutics

Via GlobeNewswire

Palvella Therapeutics Appoints Matthew E. Korenberg as Chief Financial Officer

October 17, 2024

Mr. Korenberg is a seasoned executive with significant operational and financial leadership experience, including senior roles at Ligand Pharmaceuticals (NASDAQ: LGND) and in healthcare investment...

From Palvella Therapeutics

Via GlobeNewswire

Looking Into Pieris Pharmaceuticals's Recent Short Interest ↗

May 09, 2024

Via Benzinga

PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders

September 03, 2024

From Halper Sadeh LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AFBI, ENV, PIRS, BALY on Behalf of Shareholders

August 17, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates K and PIRS on Behalf of Shareholders

August 16, 2024

From Halper Sadeh LLC

Via GlobeNewswire

PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q2 2024 ↗

August 15, 2024

Pieris Pharmaceuticals just reported results for the second quarter of 2024.

Via InvestorPlace

PIERIS PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Pieris Pharmaceuticals, Inc. - PIRS

July 24, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

Crude Oil Gains 1%; AT&T Shares Rise After Q2 Earnings ↗

July 24, 2024

Via Benzinga

ALLR Stock Alert: Allarity Therapeutics Pushes Shareholders to Back Reverse Split ↗

July 24, 2024

Allarity Therapeutics stock is up on Wednesday as the company pushes ALLR investors to vote in favor of a reverse stock split.

Via InvestorPlace

Dow Tumbles 300 Points; Tesla Shares Plunge After Q2 Results ↗

July 24, 2024

Via Benzinga

Topics Stocks

Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 24, 2024

Via Benzinga

Why Is Pieris Pharmaceuticals (PIRS) Stock Up 77% Today? ↗

July 24, 2024

Pieris Pharmaceuticals stock is up on Wednesday as PIRS investors learn of the company preparing for a merger with Palvella Therapeutics.

Via InvestorPlace

PIRS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Pieris Pharmaceuticals, Inc. Is Fair to Shareholders

July 24, 2024

From Halper Sadeh LLC

Via Business Wire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

July 24, 2024

It's time to dive into the biggest pre-market stock movers for Wednesday as we check out all of the hottest news to start the day with!

Via InvestorPlace

Palvella Therapeutics and Pieris Pharmaceuticals Announce Definitive Merger Agreement

July 24, 2024

Via ACCESSWIRE

PIRS Stock Earnings: Pieris Pharmaceuticals Reported Results for Q1 2024 ↗

May 17, 2024

Pieris Pharmaceuticals just reported results for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 16, 2024

Via Benzinga

Pieris Pharmaceuticals Announces 1-for-80 Reverse Stock Split

April 19, 2024

Via ACCESSWIRE

Pieris Pharmaceuticals Announces Strategy to Maximize Partnered Milestone and Royalty Potential

March 27, 2024

Via ACCESSWIRE

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 20, 2024

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

March 14, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

January 31, 2024

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

December 13, 2023

Via Benzinga

Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket ↗

September 27, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

September 27, 2023

Pre-market stock movers are worth keeping track of and we're helping with the biggest winners and losers for Wednesday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's Intraday Session ↗

August 25, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

August 25, 2023

Via Benzinga

Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

August 25, 2023

Gainers YS Biopharma Co., Ltd. (NASDAQ: YS) shares gained 57.6% to $1.19 in pre-market trading after the company announced the purchase of shares by company officers.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.